| Title | Author(s) | Year | View Count |
 | European guidelines on managing adverse effects of medication for ADHD | Graham, J; Banaschewski, T; Buitelaar, J; Coghill, D; Danckaerts, M; Dittmann, RW; Döpfner, M; Hamilton, R; Hollis, C; Holtmann, M; HulpkeWette, M; Lecendreux, M; Rosenthal, E; Rothenberger, A; Santosh, P; Sergeant, J; Simonoff, E; SonugaBarke, E; Wong, ICK; Zuddas, A; Steinhausen, HC; Taylor, E | 2011 | 52 |
| Attention-deficit hyperactivity disorder: Treatment discontinuation in adolescents and young adults | Mccarthy, S; Asherson, P; Coghill, D; Hollis, C; Murray, M; Potts, L; Sayal, K; De Soysa, R; Taylor, E; Williams, T; Wong, ICK | 2009 | 39 |
| Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY) - A pharmacoepidemiological and qualitative study | Wong, ICK; Asherson, P; Bilbow, A; Clifford, S; Coghill, D; Desoysa, R; Hollis, C; Mccarthy, S; Murray, M; Planner, C; Potts, L; Sayal, K; Taylor, E | 2009 | 34 |
|
